- Discussion Forum: “Driving Academic Translation on Cell and Gene Therapies”Sponsored by the Translation Partnership Award (Wellcome Trust & BIH/Charité), Berlin Center for Advanced Therapies (BeCAT), and BIH Center for Regenerative Therapies (BCRT). RESTORE looks forward to its next meeting: “Driving Academic Translation […] Read More →
Driving Academic Translation of Cell and Gene Therapies (CGT)
The event is sponsored by the Translation Partnership Award (Wellcome Trust & BIH/Charité), Berlin Center for Advanced Therapies (BeCAT), and BIH Center for Regenerative Therapies (BCRT).
The program will include case study presentations on the identification of translation barriers in the field of CGT in Europe and strategies to overcome them or reports on already successful results.
Gene Therapy 2.0
The event will be chaired by Prof. Hildegard Büning (Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany)
Bringing Advanced Therapy Medicinal Products (ATMPs) to the clinic and beyond: How to ensure the sustainable and affordable introduction of ATMPs into healthcare
The deadline for manuscript submission to the RESTORE Frontiers in Medicine topic has been extended to the 22nd of June 2021.
Participate and submit your abstract or your manuscript
Looking forward to reading your exciting contributions!
Harnessing cell therapies to fight COVID-19: Basic research, clinical evidence and patient access
The RESTORE position paper represents the cumulative efforts of the RESTORE community, and the steering committee since the start of the RESTORE initiative in 2019. It outlines, in depth, the RESTORE view on why Europe should invest in Advanced Therapies, the roadblocks in Advanced Therapy development and implementation into patient care, and makes recommendations about how Europe can tackle these hurdles to establish a sustainable pan-European ecosystem integrating research, clinics, industry and patients.
MSC Therapies for COVID-19: A Perspective Article
RESTORE partners from the Charité Universitätsmedizin Berlin have published a perspective article in Frontiers in Immunology (Vaccines and Molecular Therapeutics) about the use of mesenchymal stromal/stem cell (MSC) therapies for treating COVID-19.
The RESTORE partners have also been contributing to the intense efforts to curb the devastating spread of SARS-CoV-2 and to treat critically ill patients. We would like to share some of the efforts of the RESTORE partners in targeting and treating SARS-CoV-2/COVID-19. They are involved in a variety of research actions from compassionate treatment and clinical trials of novel therapeutics to identification of novel biomarkers, diagnostics and vaccine development.
Read the press release Download the press release
If you would like to share with RESTORE how you are fighting the virus, please tweet us @RESTOREhorizon
Large Scale Research Initiative
The visionary unifying goal of Large Scale Research Initiative RESTORE is to make the transforming promise associated with Advanced Therapies a reality for the benefit of patients and society.
RESTORE sees itself as a “place” where medicine, basic research, technology development and engineering meet, communicate and work together. Through this coordinated, financially strong, academia-industry partnership, we hope to exert a game-changing impact on Europe´s economy and society.
RESTORE Momentum Workshop
First Advanced Therapies
25 and 26 November 2019, Berlin
has been accredited by the
European Accreditation Council for Continuing Medical Education (EACCME®)
Over 200 abstracts received
Registration closure date:
15 November 2019
New material to promote RESTORE available for download:
If you are interested to participate in RESTORE activities JOIN US
RESTORE welcomes the support of all stakeholders who are committed to achieving this goal.
Please support us in our efforts to spread awareness for RESTORE and communicate the work to the scientific community and the general public.